Foldax treats first patients outside U.S. with polymer mitral heart valve
Foldax announced today that the first 30 patients have been treated outside the U.S. with its Tria polymer surgical mitral heart valve.
Related Articles
CMR leaders on the ‘massive advantage’ of Versius and growing robotic surgery penetration
CMR Surgical leaders say it’ll take the right surgical robot to expand global adoption — and that their Versius system is just the thing.
Cook Medical launches Ascend single-use ureteroscope in U.S., Canada
Cook Medical this week announced it launched its Ascend Single-Use Flexible Ureteroscope in the U.S. and Canada.
MMI’s Symani surgical robot used in first U.S. clinical cases
MMI announced the reconstructive extremity microsurgeries a month after winning FDA de novo classification for its Symani surgical robot.
Medline enters deal to acquire Ecolab’s global surgical solutions business
Medline today announced it entered into a definitive agreement to acquire Ecolab’s global surgical solutions business.
Neuromod startup IVEAcare raises $27.5M, names CEO
Minneapolis-based neuromodulation technology developer iVEAcare announced today that it raised $27.5 million in a Series A financing round.
FDA approves Medtronic’s Inceptiv closed-loop rechargeable spinal cord stimulator
Medtronic (NYSE: MDT) announced that it received FDA approval for the Inceptiv closed-loop rechargeable spinal cord stimulator (SCS) system.
FDA wants to advance health equity through home-based care
The FDA announced an initiative to reimagine the home environment as an integral part of the healthcare system and promote health equity.
Blue Arbor wins FDA breakthrough nod for neuromuscular interface
Blue Arbor Technologies announced today that it received FDA breakthrough device designation for its Restore neuromuscular interface system.
FDA clears computer-assisted thrombectomy system from Penumbra
Penumbra announced today that it received FDA clearance for and began the launch of its Lightning Flash 2.0 CAVT system.
Exo adds AI-powered cardiac, lung apps to handheld ultrasound
Exo announced today that it launched its FDA-cleared cardiac and lung AI applications for the Iris handheld ultrasound device.